Dixon Hubard Feinour & Brown’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$4.29M Sell
16,277
-1,673
-9% -$431K 0.51% 64
2022
Q1
$4.3M Buy
17,950
+700
+4% +$164K 0.43% 67
2021
Q4
$3.96M Buy
17,250
+16,211
+1,560% +$3.45M 0.38% 71
2021
Q3
$208K Buy
1,039
+39
+4% +$8.48K 0.04% 173
2021
Q2
$237K Hold
1,000
0.05% 170
2021
Q1
$242K Buy
+1,000
New +$223K 0.03% 183
2020
Q1
Sell
-1,019
Closed -$208K 170
2019
Q4
$208K Buy
+1,019
New +$187K 0.05% 171

Other funds holding CI

Dixon Hubard Feinour & Brown's CI Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its Cigna (CI) stake by 9.3% in Q2 2022, selling an estimated $431K and leaving 16,277 shares worth $4.29M. The position accounts for 0.51% of the portfolio, ranked #64.

Dixon Hubard Feinour & Brown first reported a position in CI in Q4 2019 and has held it in 7 quarters since. The position peaked at $4.3M in Q1 2022. 1,441 funds tracked by Wall St. Rank hold CI as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 16,277 shares of Cigna worth $4.29M as of Q2 2022.
  • Dixon Hubard Feinour & Brown sold 1,673 Cigna shares in Q2 2022, an estimated $431K.
  • Cigna made up 0.51% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #64 holding.
  • Dixon Hubard Feinour & Brown first reported a position in Cigna in Q4 2019 and has held it in 7 quarters since.
  • Dixon Hubard Feinour & Brown's Cigna position peaked at $4.3M in Q1 2022.
  • 1,441 funds tracked by Wall St. Rank held Cigna as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.